The Eye Care Trend Report, Volume III, supported by Allergan, examines trends impacting the eye care space from three perspectives: those of ophthalmologists, optometrists, and managed care executives. Topics covered in the comprehensive, 40-page report include: demand for eye care services, patient visits by payer, glaucoma treatments, electronic health records, formularies, prior authorization, dosing of eye drops, combination therapies, dry eye, medication adherence, vision plans versus health plans, patient outcomes, potential shortage of ophthalmologists, and expanded role for optometrists.

The report is based on results of three surveys of ophthalmologists (n=102), optometrists (n=71), and managed care executives (n=78). These survey findings were then analyzed by an independent Editorial Advisory Panel, whose 12 members also provided commentary.

Among the Report Findings:

• Clinical efficacy is the leading factor influencing medication choice, agree ophthalmologists (n=102), optometrists (n=70), and managed care executives (n=78).
• Ophthalmologists, with a 4.5 rating average on a 5-point scale (n=101), and optometrists, with a 4.4 rating (n=71), agree that combination products simplify dosing. Managed care executives agree less strongly, with a rating of 3.7 (n=78).
• All three groups see dry eye as a chronic, progressive disease but ophthalmologists (n=102) and optometrists (n=70) agree more strongly, with respective ratings of 4.4 and 4.5 on a 5-point scale compared with a rating of 3.9 by managed care executives (n=78).
• Most optometrists, 65% (n=70) but only 19% of ophthalmologists (n=102) and 31% of managed care executives (n=76) see optometrists serving as primary eye care providers currently.
  

Privacy Statement

©2017 Allergan. All rights reserved. Allergan®
and its design are trademarks of Allergan, Inc.
UNB107015_v2 10/17